Cyril MarcilhacyCellular AgricultureUK Food Standards Agency accepts Gourmey...The British Food Standards Agency (FSA) has formally accepted an application by French start-up Gourmey SAS for regulatory approval of its cultivated foie gras, a product developed using cellular agriculture … more ➔
Rheticus/EvonikCarbon captureFirst step towards scaling chemical prod...As part of the green transformation of North Rhine-Westphalia’s former coal-mining region, independent assessors have recommended the co-financing of two biotechnology processes developed at pilot … more ➔
Nuclidium AGRadiopharmaceuticalsNuclidium fuels next radiopharma waveBasel-based NUCLIDIUM AG has successfully closed a Series B financing round of CHF 79 million (EUR 84 million) to advance the development of its copper-based radiopharmaceutical platform. The round was … more ➔
Actithera Norway ASRadiopharmaceuticalsActithera: Radiopharma Funding Gathers H...The biotech company Actithera, with locations in Cambridge, USA, and Oslo, Norway, has successfully closed a major Series A round, raising US $75.5 million. Its isotope-agnostic platform — designed … more ➔
adobe stock photos - Wang Dan AdipositasCiloa SAS secures €6.5m to advance lead...French biotech Ciloa SAS has received a €6.5m grant to advance its adiponectin-loaded exosome candidate, APN-sEV, into Phase I safety trials, ahead of efficacy evaluation in indications including type … more ➔
Solar FoodsFood BiotechnologySolar Foods continues expansion in the USAfter Finnish protein powder producer Solarfoods signed a strategic agreement with two US food manufacturers to supply 6,000 tonnes of Solein from 2030 onwards, the company has now announced a more concrete … more ➔
ECEuropean CommissionEuropean Commission to fund Life Science...The European Commission last week unveiled its Life Sciences Strategy, which aims to elevate Europe’s biotechnology sector from third to first place globally by 2030, backed by an investment of €10bn. … more ➔
SandozBiomanufacturingSandoz breaks ground on US$440m biosimil...Biosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn. more ➔
Unnatural Products IncPartnershipArgenx and Unnatural Products ink US$1.5...California oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs … more ➔
Vetter Pharma International GmbHCDMOVetter invests US$285m in Chicago produc...CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of … more ➔
Cyril Marcilhacy
Rheticus/Evonik
Nuclidium AG
Actithera Norway AS
adobe stock photos - Wang Dan 
Solar Foods
EC
Sandoz
Unnatural Products Inc
Vetter Pharma International GmbH